Introduction
Percutaneous transluminal coronary angioplasty (PTCA) has become routine treatment for coronary artery disease. Since its introduction by Grü ntzig et al. [1, 2] in 1977, the initial success rate has increased from 79% to more than 90% and the complication rate decreased to less than 5% [3] . The indications for PTCA have also been extended to more complex stenoses, multivessel disease, unstable angina, and acute myocardial infarction [4, 5] . Nevertheless, the high restenosis rate of 30-50% is a significant disadvantage of PTCA [6] [7] [8] [9] . Although reduction of this high restenosis rate has been the aim of innumerable studies, to date only intracoronary stent implantation has brought any noteworthy results [10, 11] , none has examined whether restenosis significantly affects the patients' long-term outcome. In the present study, we therefore examined the long-term outcome in patients with and without restenosis 10 years after PTCA.
Patients and methods

Inclusion criteria and definitions
Between 1983 and 1986, 555 patients underwent singlevessel PTCA in our department. Follow-up data on symptoms and cardiac events, such as myocardial infarction, repeat PTCA, and bypass surgery were obtained by questionnaire for 534 of the 555 patients (96·2%). The mean time following single-vessel PTCA was 10 years (121 11 months). In this report, we describe the long-term follow-up of patients who had had successful PTCA and who underwent a control angiogram 6 months following the PTCA (6 month control). Angioplasty was considered successful when it resulted in at least a 20% reduction in luminal diameter narrowing without any major complication (death, myocardial infarction, or emergency bypass surgery). This value was chosen with regard to the definition of successful PTCA used 10 years ago [12] (National Heart, Lung, and Blood Institute PTCA Registry) and because a 20% stenosis reduction is generally accompanied by disappearance or pronounced amelioration of symptoms [12] . All patients with successful PTCA were advised to undergo a 6 month control.
Of the 534 patients, 103 (19%) on whom data were obtained were excluded because dilatation had not been successful (Fig. 1) . Another 33 patients (6%) were excluded because of cardiac events during the first 6 months immediately following PTCA. Of the remaining 398 (75%) patients, 85 patients were excluded because they did not undergo a 6 month control. Three hundred and thirteen (79%) patients who fulfilled the study criteria, including a 6 month control, were included in the study. Patients without restenosis at the 6 month control were defined as group A (226 patients 72%). In accordance with previous reports [9] restenosis was defined as loss of more than 50% of the initial gain and a stenosis of more than 50%. Restenosis was found in 87 of the 313 patients (28%, group B). Events were defined as death from any cause, non-fatal myocardial infarction, bypass surgery (coronary artery bypass grafting -CABG) or second PTCA. Event-free survival was defined as survival without any cardiac event.
Procedure
PTCA was performed if a stenosis measured at least 50% and typical anginal symptoms or ECG signs of ischaemia were present. The same indication was used for repeat angioplasty if a restenosis was detected 6 months following PTCA. Informed consent was obtained from all patients. A surgical team was on call during the procedure. The procedure was performed according to the technique of Grü ntzig et al. [1] , via the femoral route. After January 1984, a steerable dilatation system was used. All patients received 20 mg nifedipine and 500 mg aspirin three times a day [12] for 2 days, if possible starting the day before the procedure. During the procedure, intravenous heparin (10 000-15 000 IU) and a continuous drip of low-molecular-weight dextran were given. A Swan-Ganz catheter was placed into the pulmonary artery. Immediately after the procedure, heparin (3000 U) and nitroglycerin (0·2 mg) were injected into the diseased coronary artery to prevent thrombus formation and coronary spasm [4, 13] . Coronary angiography was performed after PTCA in multiple projections to document the result. After the PTCA procedure, the femoral sheath was left in the groin for 24 h [14] , during which time all patients received intravenous heparin. The severity of coronary lesions was measured using a digital electronic caliper system [15] at the maximum percentage diameter narrowing in any standard angulation.
Statistical methods
Statistical analysis was performed using SAS programs. Differences in categorical variables between the patients with and without restenosis were compared using Chi-square analysis and the two-sided Fisher test. For comparison of continuous variables, the Wilcoxon two-sample test was used. Event-free survival was evaluated according to the life-table analysis (Kaplan-Meier). Differences in the life-table analysis were evaluated using the log-rank test. Multivariate, stepwise logistic regression analysis was used to evaluate predictors of long-term, event-free survival in two statistical models, patient-related parameters (age, sex, unstable angina, previous myocardial infarction, angina class at time of control angiography, multivessel disease) in one and lesion parameters (LAD, LCX, RCA, proximal, medial, distal location, severity of stenosis before PTCA (%), length of stenosis before PTCA (mm), eccentricity, retenosis) in the other, related to cardiac events. Risk stratification of significant parameters was by exponential parameter estimates (parameter estimate= , e ). P value <0·05 was considered significant.
Results
Baseline characteristics
Mean age and gender were similar in patients with and without restenosis ( pts.
Figure 1 Patients (pts.) excluded from the evaluation.
restenosis contained a significantly higher percentage of patients with a family history of coronary artery disease (P<0·05). Other cardiovascular risk factors were similar in the two groups. Significantly more patients with restenosis had unstable angina at the time of PTCA (P<0·05) than those without. Patients with restenosis were in a higher angina class at the time of the 6-month control compared to patients without restenosis. Lesion location within the coronary tree was comparable between the two groups. Most lesions were located in the left anterior descending artery (LAD). The degree of stenosis was reduced from 76·7 14% to 19·3 16% in group A and from 81·3 13% to 27·0 16% in group B (P<0·01). Stenosis at the time of control angiography was 26·7 16% in group A and 76·6 14% in group B (P<0·0001).
Cardiac events
During the long-term follow-up period, 11 (5%) of the 226 patients without restenosis and 11 (13%) of the 87 patients with restenosis died (P<0·05, Table 2 ). Death not related to the heart disease was reported for four patients in each group. In group A, 17 (8%) patients and in group B, 11 (13%) patients suffered myocardial infarction (ns); 17 group A (8%) patients and 25 (29%) group B patients had bypass surgery (P<0·0001), and 34 (15%) group A patients and 55 (63%) group B patients underwent repeat PTCA (P<0·0001). In the group of patients with restenosis, 20 patients (23%) and in the group of patients without restenosis, 26 patients (12%) suffered non-fatal myocardial infarction or died (P<0·01, Fig. 2 ). At the end of followup, 163 (72%) group A patients and 15 (17%) group 
Life-table analysis
The life-table analysis compares the rate of cardiac events during the 10-year follow-up between patients with and without restenosis (Fig. 3) . The survival rate in patients with restenosis was significantly poorer than in patients without restenosis ( Fig. 3(a), P<0·05) . The difference between the two groups of patients arises mainly within the first 3 years of follow-up. Figure 3(b) shows that, although patients with restenosis had a slightly higher rate of myocardial infarction, the difference was not significant. As expected, there was a significant difference in the incidence of further angioplasty procedures and bypass operations between patients with and without restenosis (Fig. 3(c) and (d) ). 
Logistic regression analysis
To evaluate the importance of restenosis as an independent factor affecting the incidence of cardiac events, we performed stepwise logistic regression analysis using two statistical models, covering patient-related variables in one and lesion parameters in the other. In the clinical model, the risk of death was increased 2·8-fold by a previous myocardial infarction (P<0·05, Table 3 ). The risk of CABG was increased by the presence of multivessel disease (2·5-fold, P<0·05) and by a higher class of angina at the time of control angiography (1·7-fold, P<0·001). Repeat PTCA was performed more often in the presence of a higher CCS class (2·3-fold, P<0·0001, Table 3 ). There were no patient-related or lesion predictors of myocardial infarction. In the morphological model, restenosis was identified as the only parameter increasing the risk of death (2·8-fold, P<0·02, Table 4 ) and CABG (5·6-fold, P<0·0001). The risk of repeat PTCA was increased 2·5-fold by a distal location of stenosis (P<0·05) and 10-fold by the presence of restenosis (P<0·0001).
Discussion
Although restenosis significantly limits the success of PTCA, ranging between 17% and 53% in previous reports [6] [7] [8] [9] [16] [17] [18] , there is little information available so far as to whether the occurrence of restenosis influences the long-term prognosis of patients after PTCA. Therefore, we evaluated the long-term outcome of patients with or without angiographic restenosis after successful PTCA and an event-free, 6-month follow-up period. The restenosis rate of 28% in our patient group is comparable with that in previously published studies [6] [7] 19, 20] . Unstable angina, a higher degree of stenosis before PTCA, or a higher degree of residual stenosis immediately after PTCA were identified as risk factors for developing restenosis during the 6-month follow-up period. Similar results have also been reported by Meyer et al. [16] , Leimgruber et al. [6] , Rose et al. [21] , and Rupprecht et al. [14] . It was remarkable that no patient without restenosis died during the first 4 years of follow-up, whereas patients with restenosis died even during the first year of follow-up. During long-term follow-up, there was significantly higher mortality in patients with restenosis than in those without. This might be related to invasive procedures, such as repeat PTCA or CABG for the treatment of restenosis [22, 23] . On the other hand, patients with retenosis and repeat PTCA may develop a second restenosis, which might remain undetected in those who do not undergo another angiographic control. Such a second restenosis might lead to death or non-fatal myocardial infarction. Restenosis was identified by logistic regression analysis as an independent, lesionrelated variable that increases mortality. There was a slight, but not significant difference in the rate of non-fatal myocardial infarction between patients with restenosis and patients with no restenosis. Restenosis often presents as recurrent angina [7, 24] . Since restenotic lesions tend to be more fibromuscular than native lipid-laden plaques, it has been assumed that restenotic lesions are less likely to undergo plaque rupture with subsequent acute coronary syndromes [25, 26] . Myocardial infarction is therefore rarely the consequence of later restenosis, which usually results from disease progression and plaque rupture at other sites. As reported by Joelson et al. [27] , recurrence of symptoms more than 6 months after the initial procedure usually represents progression of coronary artery disease in other vessels rather than restenosis. Accordingly, no lesion-or patient-related factor was found to be a predictor of myocardial infarction by logistic regression analysis and, hence, the risk of acute myocardial infarction during long-term follow-up was comparable in the two groups. Previous myocardial infarction was found to be a patient-related risk factor for long-term morality in the logistic regression analysis.
The event-free survival rate was 72% in patients without restenosis and 17% in patients with restenosis. There was still a significant difference between the two groups for a combined end-point of death and myocardial infarction (Fig. 2) .
Our data suggest that avoiding restenosis significantly improves event-free survival following successful PTCA. Coronary interventions should therefore be aimed at achieving a restenosis rate which is as low as possible. Many new technologies have been developed in an effort to reduce angiographic restenosis, but up to now its seems that only intracoronary stent implantation results in a significant reduction of restenosis in humans [9] [10] [11] . The cost of stent application is higher than only PTCA at the time of angioplasty, but the cost of restenosis in the long term, including repeat-PTCA, bypass surgery and hospitalization during myocardial infarction, should not be underestimated. Several other approaches to reduce restenosis after PTCA have been studied, such as the administration of proliferation inhibiting drugs during PTCA by local drug delivery systems and genetic therapies [8, 9, 28, 29] . Altering the lipoprotein profile may also reduce restenosis after PTCA and agents that affect the lipoprotein profile may prove to be powerful in reducing restenosis and deserve to be explored in future trials [30, 31] .
Limitations
The results are based on retrospective data, and we only included patients in this study who had undergone a 6-month control. This is a limitation of the study because some patients without clinical symptoms who are not examined angiographically might still have had restenosis. In addition, after 10 years no objective parameter of cardiac ischaemia, such as exercise testing or repeat coronary angiography, was available. It must also by emphasized that the baseline characteristics of the patients who underwent PTCA 10 years ago are different from those patients of today. The patients in our study were younger and only 13% of the patients had multivessel disease. Patients who undergo PTCA today are older, and more patients with multivessel disease are treated. The improvements in devices and operator experience allow PTCA to be used in more complex lesions today, with better results.
Conclusions
The occurrence of restenosis 6 months after an initially successful PTCA was associated with a worse prognosis during a 10-year follow-up period compared to patients without restenosis. There was not only a higher incidence of repeat interventions, such as CABG and repeat PTCA but also a higher rate of death and myocardial infarction in patients with retenosis. Coronary interventions should therefore be aimed at achieving restenosis rate which is as low as possible. Several trials have demonstrated the value of intracoronary stent implantation in this regard [9] [10] [11] .
